X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Wockhardt with Novartis - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WOCKHARDT LTD. vs NOVARTIS - Comparison Results

WOCKHARDT LTD.    Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

NOVARTIS 
   Change

Novartis is a 76% subsidiary of Novartis AG - Switzerland and has a countrywide presence in the healthcare business. While pharmaceuticals contributes 70% to total revenues (FY10), generics (6%), consumer healthcare i.e. OTC (14%) and animal health (... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WOCKHARDT LTD. NOVARTIS WOCKHARDT LTD./
NOVARTIS
 
P/E (TTM) x 16.1 340.1 4.7% View Chart
P/BV x 1.6 16.7 9.8% View Chart
Dividend Yield % 0.0 1.7 -  

Financials

 WOCKHARDT LTD.   NOVARTIS
EQUITY SHARE DATA
    WOCKHARDT LTD.
Mar-16
NOVARTIS
Mar-16
WOCKHARDT LTD./
NOVARTIS
5-Yr Chart
Click to enlarge
High Rs2,000982 203.7%   
Low Rs706556 126.9%   
Sales per share (Unadj.) Rs403.7252.9 159.6%  
Earnings per share (Unadj.) Rs29.562.1 47.4%  
Cash flow per share (Unadj.) Rs42.463.3 66.9%  
Dividends per share (Unadj.) Rs010.00 0.0%  
Dividend yield (eoy) %01.3 0.0%  
Book value per share (Unadj.) Rs323.4363.6 88.9%  
Shares outstanding (eoy) m110.5131.96 345.8%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.43.0 110.2%   
Avg P/E ratio x45.912.4 370.9%  
P/CF ratio (eoy) x31.912.2 262.8%  
Price / Book Value ratio x4.22.1 197.8%  
Dividend payout %016.1 0.0%   
Avg Mkt Cap Rs m149,50924,580 608.2%   
No. of employees `0007.40.8 980.9%   
Total wages/salary Rs m9,4431,801 524.3%   
Avg. sales/employee Rs Th6,048.610,748.9 56.3%   
Avg. wages/employee Rs Th1,280.22,395.2 53.4%   
Avg. net profit/employee Rs Th441.52,641.1 16.7%   
INCOME DATA
Net Sales Rs m44,6148,083 551.9%  
Other income Rs m970829 116.9%   
Total revenues Rs m45,5848,913 511.5%   
Gross profit Rs m5,038234 2,151.3%  
Depreciation Rs m1,42637 3,884.5%   
Interest Rs m1,0122 56,227.8%   
Profit before tax Rs m3,5701,025 348.3%   
Minority Interest Rs m-650-   
Prior Period Items Rs m617 38.3%   
Extraordinary Inc (Exp) Rs m01,696 0.0%   
Tax Rs m255752 33.9%   
Profit after tax Rs m3,2571,986 164.0%  
Gross profit margin %11.32.9 389.8%  
Effective tax rate %7.173.4 9.7%   
Net profit margin %7.324.6 29.7%  
BALANCE SHEET DATA
Current assets Rs m39,90612,678 314.8%   
Current liabilities Rs m18,4232,433 757.2%   
Net working cap to sales %48.2126.7 38.0%  
Current ratio x2.25.2 41.6%  
Inventory Days Days9033 275.8%  
Debtors Days Days9822 436.7%  
Net fixed assets Rs m35,83269 51,780.6%   
Share capital Rs m553160 345.7%   
"Free" reserves Rs m30,37011,460 265.0%   
Net worth Rs m35,73911,621 307.5%   
Long term debt Rs m16,5420-   
Total assets Rs m79,52214,400 552.3%  
Interest coverage x4.5570.5 0.8%   
Debt to equity ratio x0.50-  
Sales to assets ratio x0.60.6 99.9%   
Return on assets %5.413.8 38.9%  
Return on equity %9.117.1 53.3%  
Return on capital %8.723.6 36.7%  
Exports to sales %11.60.7 1,558.0%   
Imports to sales %4.518.6 24.0%   
Exports (fob) Rs m5,17760 8,599.2%   
Imports (cif) Rs m1,9901,503 132.4%   
Fx inflow Rs m7,589186 4,073.5%   
Fx outflow Rs m2,8781,821 158.1%   
Net fx Rs m4,711-1,635 -288.2%   
CASH FLOW
From Operations Rs m7162,531 28.3%  
From Investments Rs m-8,182-8,270 98.9%  
From Financial Activity Rs m2,543-386 -659.2%  
Net Cashflow Rs m-4,923-6,125 80.4%  

Share Holding

Indian Promoters % 74.5 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 2.3 2.0 115.0%  
FIIs % 7.7 1.6 481.3%  
ADR/GDR % 0.1 0.0 -  
Free float % 15.4 21.5 71.6%  
Shareholders   67,757 41,647 162.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WOCKHARDT LTD. With:   PLETHICO PHARMA  DIVIS LABORATORIES  UNICHEM LAB  ALKEM LABORATORIES  AJANTA PHARMA  

Compare WOCKHARDT LTD. With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Post Noon Sell-Off; Infosys Falls 5.4%(Closing)

Share markets in India witnessed a sharp fall in the final minutes of trade. At the closing bell, the BSE Sensex closed lower by 266 points. While, the NSE Nifty finished lower by 83 points.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Profitable Investment in the History of the World(Vivek Kaul's Diary)

Aug 8, 2017

'Yes, it looks like a bubble. And, yes, it's like buying a lottery ticket. But there's something happening that has never happened before. It's an evolutionary leap in money itself.'

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

WOCKHARDT LTD. SHARE PRICE


Aug 21, 2017 03:37 PM

TRACK WOCKHARDT LTD.

  • Track your investment in WOCKHARDT LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON WOCKHARDT LTD.

WOCKHARDT LTD. 8-QTR ANALYSIS

COMPARE WOCKHARDT LTD. WITH

MARKET STATS